Search Results 301-310 of 17539 for Assay
A version of this storyOpens in new tab appears on the Mayo Clinic News Network. Armin Garmany sets up assay samples with a pipette and microtube in the ...
... assay, Dr. Bartemes seeks to identify changes in the immune cell repertoire after surgical or other medical intervention. Further, she compares immune ...
Exploring novel disease mechanisms. Our lab uses cutting-edge assays to evaluate the pathophysiology of kidney disease.
The lab has developed assays that specifically detect phosphorylated ubiquitin, which serves as a selective, quantitative label of damaged mitochondria.
Midthun is the site principal investigator for the Cancer Screening Assay Using DELFI (CASCADE-LUNG) study and the Screening for High Frequency Malignant ...
Also developed by Mayo Clinic Laboratories, this assay points to somatic hypermutation status, if present. Hematologic neoplasms (TP53) somatic mutation, DNA ...
... assay. Building on results of previous tissue and pilot plasma testing, Dr. Majumder and colleagues are testing a panel of candidate plasma methylated DNA ...
... assay. Also, the lab has identified the low-density lipoprotein receptor-related protein 1 (LRP1), a well-characterized APOE receptor, as a key regulator of ...
The Vaccine Research Group uses immunological testing, including serology, cell-mediated immunity, cell culture and cytokine assays; polymerase chain reaction ( ...
Ceramide testing is a novel assay that can reveal more about heart disease and stroke risk than standard lipid tests.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.